Trial Profile
Anti-inflammatory effect of telmisartan in patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 17 Nov 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 05 Dec 2012 New trial record